Game-changing drug can help obese patients lose 20% of their body weight – BGR

• The obesity rate in the US has skyrocketed over the last decade and is currently at a record high.
• Clinical trials involving the drug semaglutide saw obese patients lose an average of 33 pounds in a little over a year.
• The drugmaker Novo Nordisk has already applied for FDA approval to use the drug — which is currently used to combat Type 2 Diabetes — as an anti-obesity medication.

The obesity rate in America has soared over the past few years, primarily because unhealthy eating habits and sedentary…

Click here to view the original article.